$SGMO SANGAMO THERAPEUTICS, INC Insider Trading
Get free email notifications about insider trading in SANGAMO THERAPEUTICS, INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in SANGAMO THERAPEUTICS, INC. Insider overview, share value development, latest insider transactions and email notifications about new events in SANGAMO THERAPEUTICS, INC for free.
IRS Number: 680359556
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: SGMO
Company Address: 7000 MARINA BLVD BRISBANE 94005
Former name: SANGAMO BIOSCIENCES INC, date of change: 2000-02-08
Sangamo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins. It focuses on three therapeutic areas: inherited metabolic diseases, central nervous system, and diseases and immunology, which comprises inflammatory and autoimmune diseases. It also offers complementary technology platforms such as gene therapy, ex vivo cell therapy, in vivo genome editing, and in vivo genome regulation. The company was founded by Edward O. Lanphier II in 1995 and is headquartered in Brisbane, CA.
Market Capitalization: $254.24M
Prev close: $3.85
Average Daily Volume: 923,424
Days Low: $3.55
Year Low: $2.65
Year High: $7.60
SANGAMO THERAPEUTICS, INC Insiders Active In Last 3 Months
Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
---|---|---|---|---|---|---|---|
Ramasastry Saira | Director | 25,000 | 96,250 | shares bought: 31,950 / shares sold: -24,450 | BUY | Dec 18 2020 | 1 month ago |
Ramelmeier Rolf Andrew | EVP, Technical Operations | 65,978 | 254,015 | shares bought: 55,000 / shares sold: -7,498 | BUY | Jan 06 2021 | 19 days ago |
View all SANGAMO THERAPEUTICS, INC insiders.
SANGAMO THERAPEUTICS, INC Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 06 2021 | SGMO | SANGAMO THERAPEUTI ... | Ramelmeier Rolf Andrew | EVP, Technical Oper ... | Sell | S | 16.74 | 2,464 | 41,247 | 65,978 | 68.4 K to 66 K (-3.60 %) |
Dec 30 2020 | SGMO | SANGAMO THERAPEUTI ... | Ramelmeier Rolf Andrew | EVP, Technical Oper ... | Sell | S | 18.13 | 3,331 | 60,391 | 68,442 | 71.8 K to 68.4 K (-4.64 %) |
Dec 18 2020 | SGMO | SANGAMO THERAPEUTI ... | Ramasastry Saira | Director | Option Exercise | M | 5.99 | 10,000 | 59,900 | 0 | |
Dec 18 2020 | SGMO | SANGAMO THERAPEUTI ... | Ramasastry Saira | Director | Sell | S | 13.27 | 10,000 | 132,747 | 15,000 | 25 K to 15 K (-40.00 %) |
Dec 18 2020 | SGMO | SANGAMO THERAPEUTI ... | Ramasastry Saira | Director | Buy | M | 5.99 | 10,000 | 59,900 | 25,000 | 15 K to 25 K (+66.67 %) |
Sep 11 2020 | SGMO | SANGAMO THERAPEUTI ... | Hillan Kenneth J. | Director | Option Exercise | A | 10.43 | 30,000 | 312,900 | 30,000 | |
Sep 11 2020 | SGMO | SANGAMO THERAPEUTI ... | Hillan Kenneth J. | Director | Grant | A | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
Jul 31 2020 | SGMO | SANGAMO THERAPEUTI ... | Boissel Stephane | EVP, Corp. Strategy | Option Exercise | E | 0.00 | 1 | 0 | 1 | |
Jul 31 2020 | SGMO | SANGAMO THERAPEUTI ... | Boissel Stephane | EVP, Corp. Strategy | Option Exercise | E | 0.00 | 1 | 0 | 2 | |
Jun 29 2020 | SGMO | SANGAMO THERAPEUTI ... | McClung David Mark | EVP, Chief Business ... | Option Exercise | A | 9.16 | 200,000 | 1,832,000 | 200,000 | |
Jun 29 2020 | SGMO | SANGAMO THERAPEUTI ... | McClung David Mark | EVP, Chief Business ... | Grant | A | 0.00 | 100,000 | 0 | 100,000 | 0 to 100 K |
Jun 05 2020 | SGMO | SANGAMO THERAPEUTI ... | Boissel Stephane | EVP, Corp. Strategy | Option Exercise | M | 2.09 | 1 | 2 | 2 | |
Jun 05 2020 | SGMO | SANGAMO THERAPEUTI ... | Boissel Stephane | EVP, Corp. Strategy | Sell | D | 11.23 | 14,907 | 167,406 | 70,116 | 85 K to 70.1 K (-17.53 %) |
Jun 05 2020 | SGMO | SANGAMO THERAPEUTI ... | Boissel Stephane | EVP, Corp. Strategy | Buy | M | 0.00 | 14,907 | 0 | 85,023 | 70.1 K to 85 K (+21.26 %) |
Jun 05 2020 | SGMO | SANGAMO THERAPEUTI ... | Boissel Stephane | EVP, Corp. Strategy | Option Exercise | M | 2.09 | 1 | 2 | 2 |